Privia Health Group, Inc. Acquisitions, Net of Cash Acquired
Privia Health Group, Inc. (PRVA) reported Acquisitions, Net of Cash Acquired of $11.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-06
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $91.31M, a 1360.99% increase year-over-year.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $0.00.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-06-30 was $89.06M.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $180.37M, a 2492.64% increase from fiscal 2024.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $6.96M, a 83.77% decline from fiscal 2023.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $42.86M.
- Privia Health Group, Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.43M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $91.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $91.31M derived: sum of 2 quarters · filed 2026-02-27 | $180.37M derived: sum of 3 quarters · filed 2026-08-06 | $180.37M 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $89.06M derived: sum of 2 quarters · filed 2026-08-06 | $89.06M 10-Q · filed 2025-11-06 | $95.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $89.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $89.06M 10-Q · filed 2026-08-06 | $95.31M derived: sum of 3 quarters · filed 2026-08-06 | $95.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $6.25M derived: sum of 2 quarters · filed 2026-02-27 | $6.25M derived: sum of 3 quarters · filed 2026-02-27 | $6.25M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | $6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $6.25M derived: sum of 2 quarters · filed 2026-02-27 | $6.25M derived: sum of 3 quarters · filed 2026-02-27 | $6.96M 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $707.00K 10-Q · filed 2025-11-06 | $5.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $707.00K 10-Q · filed 2025-08-07 | $5.71M derived: sum of 3 quarters · filed 2026-02-27 | $18.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $707.00K 10-Q · filed 2025-05-08 | $5.71M derived: sum of 2 quarters · filed 2026-02-27 | $18.71M derived: sum of 3 quarters · filed 2026-02-27 | $18.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.00M derived: sum of 2 quarters · filed 2026-02-27 | $18.00M derived: sum of 3 quarters · filed 2026-02-27 | $42.86M 10-K · filed 2026-02-27 |
| 2023-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $13.00M derived: sum of 2 quarters · filed 2024-11-07 | $37.86M 10-Q · filed 2024-11-07 | $37.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $24.86M 10-Q · filed 2024-08-08 | $24.86M derived: sum of 3 quarters · filed 2025-02-27 | $24.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $24.86M 10-Q · filed 2024-05-09 | $24.86M derived: sum of 2 quarters · filed 2025-02-27 | $24.86M derived: sum of 3 quarters · filed 2025-02-27 | $24.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $32.23M 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |